Comparison

VEGFA Polyclonal Antibody

Item no. E-AB-52121-120
Manufacturer Elabscience
Amount 120uL
Category
Type Antibody Polyclonal
Applications WB, ELISA
Specific against Human, Mouse
Host Rabbit
Isotype IgG
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen, MGC70609, MVCD1, Vascular endothelial growth factor A, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular endothelial growth fac
Similar products VEGF-A, VEGFA, Vascular endothelial growth factor A, Vascular permeability factor, Vegfa, VPF, MGC70609, MVCD1, VEGF A, VEGF120, Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular endothelial growth factor, Vegf
Available
Research Areas
Cancer, Cardiovascular, Metabolism, Developmental Biology, Signal Transduction
Synonyms
Folliculostellate cell-derived growth factor, Glioma-derived endothelial cell mitogen, MGC70609, MVCD1, Vascular endothelial growth factor A, vascular endothelial growth factor A121, vascular endothelial growth factor A165, vascular endothelial growth factor, Vascular permeability factor, VEGF A, Vegf, VEGF-A, VEGF120, Vegfa, VEGFA, VPF
Swissprot
P15692
Background
This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site.
Concentration
1.3 mg/mL
Storage
Store at -20C. Avoid freeze / thaw cycles.
Immunogen
Synthetic peptide of human VEGFA
Buffer
PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method
Antigen affinity purification
Dilution
WB 1:1000-1:5000, ELISA 1:5000-1:10000
Conjugation
Unconjugated
Calculated MW
27 kDa
Observed MW
Refer to figures
Gene Accession
NP001020537

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 120uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close